ResearcherNational Cancer Centre JapanActive in the last 2 years
Yasuhiro Matsumura
Matched on ORCID iD 0000-0003-4331-8177; OpenAlex author ID A5028273614. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 8
- Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models. Co-author DOI 10.1111/cas.16335↗
- The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer… Co-author DOI 10.1016/j.tranon.2021.101285↗
- Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer. Last author DOI 10.3892/or.2020.7850↗
- Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. Co-author DOI 10.3892/or.2019.7017↗
- Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targetability into Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.8b00507↗
- Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. Co-author DOI 10.3748/wjg.v24.i48.5491↗
- Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.10.069↗
- The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation an… Last author DOI 10.1016/j.ejca.2011.04.028↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masahiro Yasunaga · 7 shared papers, 2011–2024 · strength 0.82
- Paper Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models. DOI 10.1111/cas.16335↗
- Paper The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunother… DOI 10.1016/j.tranon.2021.101285↗
- Paper Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreat… DOI 10.3892/or.2020.7850↗
- Ryo Tsumura · 3 shared papers, 2015–2024 · strength 0.45
- Paper Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models. DOI 10.1111/cas.16335↗
- Paper Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreat… DOI 10.3892/or.2020.7850↗
- Paper Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. DOI 10.1016/j.biomaterials.2014.10.069↗
- Aya Sugyo · 3 shared papers, 2018–2022 · strength 0.34
- Paper The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunother… DOI 10.1016/j.tranon.2021.101285↗
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. DOI 10.3748/wjg.v24.i48.5491↗
- Tatsuya Higashi · 3 shared papers, 2018–2022 · strength 0.34
- Paper The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunother… DOI 10.1016/j.tranon.2021.101285↗
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. DOI 10.3748/wjg.v24.i48.5491↗
- Winn Aung U · 2 shared papers, 2018–2019 · strength 0.19
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. DOI 10.3748/wjg.v24.i48.5491↗
- Yoichi Takakusagi · 1 shared paper, 2022 · strength 0.16
- Kazunori Kataoka · 2 shared papers, 2015–2018 · strength 0.12
- Paper Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targeta… DOI 10.1021/acs.biomac.8b00507↗
- Paper Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. DOI 10.1016/j.biomaterials.2014.10.069↗
- Jooyeon Ahn · 2 shared papers, 2015–2018 · strength 0.12
- Paper Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targeta… DOI 10.1021/acs.biomac.8b00507↗
- Paper Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. DOI 10.1016/j.biomaterials.2014.10.069↗
- Tsuneo Saga · 1 shared paper, 2019 · strength 0.10
- Hyun Su Min · 1 shared paper, 2018 · strength 0.08
- Horacio Cabral · 1 shared paper, 2015 · strength 0.04
- Amane Takahashi · 1 shared paper, 2011 · strength 0.03
- Yohei Saito · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.